{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:46:02Z","timestamp":1785836762050,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Liaoning Provincial Applied Basic Research Program","award":["Project No. 2025JH2\/101330088"],"award-info":[{"award-number":["Project No. 2025JH2\/101330088"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12539-7","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:02:08Z","timestamp":1785834128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circ_0001495 promotes bladder cancer progression by regulating miR-1184 via MAPK signaling pathway"],"prefix":"10.1007","volume":"53","author":[{"given":"Shoupeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"1","key":"12539_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"12539_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC et al (2023) Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol 20(5):287\u2013304","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"12539_CR3","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL et al (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345","journal-title":"CA Cancer J Clin"},{"key":"12539_CR4","doi-asserted-by":"publisher","first-page":"04109","DOI":"10.7189\/jogh.13.04109","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health 13:04109","journal-title":"J Glob Health"},{"issue":"5","key":"12539_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molmed.2022.03.003","volume":"28","author":"SY Wen","year":"2022","unstructured":"Wen SY, Qadir J, Yang BB (2022) Circular RNA translation: novel protein isoforms and clinical significance. Trends Mol Med 28(5):405\u2013420","journal-title":"Trends Mol Med"},{"issue":"1","key":"12539_CR6","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL et al (2021) Cancer Statistics, 2021. CA Cancer J Clin 71(1):7\u201333","journal-title":"CA Cancer J Clin"},{"issue":"10364","key":"12539_CR7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E et al (2022) Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet 400(10364):1712\u20131721","journal-title":"Lancet"},{"issue":"19","key":"12539_CR8","doi-asserted-by":"publisher","first-page":"e2310735","DOI":"10.1002\/adma.202310735","volume":"36","author":"K Liu","year":"2024","unstructured":"Liu K et al (2024) Drug-Loaded Bacillus Calmette-Gu\u00e9rin Bacteria for Immuno-Chemo Combo Therapy in Bladder Cancer. Adv Mater 36(19):e2310735","journal-title":"Adv Mater"},{"key":"12539_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145666","author":"M Rouanne","year":"2022","unstructured":"Rouanne M et al (2022) BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. J Clin Invest, 132(12):e145666 https:\/\/doi.org\/10.1172\/JCI145666","journal-title":"J Clin Invest"},{"key":"12539_CR10","doi-asserted-by":"crossref","unstructured":"Fang Q et al (2025) Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting, in Protein Pept Lett. Netherlands, pp 597\u2013609","DOI":"10.2174\/0109298665403178250806111943"},{"issue":"3","key":"12539_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","volume":"29","author":"S Misir","year":"2022","unstructured":"Misir S, Wu N, Yang BB (2022) Specific expression and functions of circular RNAs. Cell Death Differ 29(3):481\u2013491","journal-title":"Cell Death Differ"},{"issue":"7441","key":"12539_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384\u2013388","journal-title":"Nature"},{"issue":"3","key":"12539_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS et al (2022) The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 19(3):188\u2013206","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"12539_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12935-020-01703-z","volume":"21","author":"D Cheng","year":"2021","unstructured":"Cheng D et al (2021) Cancer-related circular RNA: diverse biological functions. Cancer Cell Int 21(1):11","journal-title":"Cancer Cell Int"},{"issue":"2","key":"12539_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","volume":"365","author":"S Qu","year":"2015","unstructured":"Qu S et al (2015) Circular RNA: A new star of noncoding RNAs. Cancer Lett 365(2):141\u2013148","journal-title":"Cancer Lett"},{"issue":"3","key":"12539_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2217\/epi-2019-0295","volume":"12","author":"X Geng","year":"2020","unstructured":"Geng X et al (2020) Circular RNA: biogenesis, degradation, functions and potential roles in mediating resistance to anticarcinogens. Epigenomics 12(3):267\u2013283","journal-title":"Epigenomics"},{"issue":"8","key":"12539_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y et al (2015) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25(8):981\u2013984","journal-title":"Cell Res"},{"issue":"10","key":"12539_CR18","doi-asserted-by":"publisher","first-page":"e0141214","DOI":"10.1371\/journal.pone.0141214","volume":"10","author":"S Pfeffer","year":"2015","unstructured":"Pfeffer S et al (2015) Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood. PLoS ONE 10(10):e0141214","journal-title":"PLoS ONE"},{"issue":"1","key":"12539_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","volume":"61","author":"JH Bahn","year":"2015","unstructured":"Bahn JH et al (2015) The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem 61(1):221\u2013230","journal-title":"Clin Chem"},{"key":"12539_CR20","doi-asserted-by":"publisher","first-page":"736546","DOI":"10.3389\/fonc.2021.736546","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) The Value of Circulating Circular RNA in Cancer Diagnosis, Monitoring, Prognosis, and Guiding Treatment. Front Oncol 11:736546","journal-title":"Front Oncol"},{"issue":"1","key":"12539_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-020-01298-z","volume":"20","author":"S Wang","year":"2021","unstructured":"Wang S et al (2021) Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol Cancer 20(1):13","journal-title":"Mol Cancer"},{"issue":"11","key":"12539_CR22","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Gla\u017ear","year":"2014","unstructured":"Gla\u017ear P, Papavasileiou P, Rajewsky N (2014) circBase: a database for circular RNAs. RNA 20(11):1666\u20131670","journal-title":"RNA"},{"issue":"12","key":"12539_CR23","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"CX Liu","year":"2022","unstructured":"Liu CX, Chen LL (2022) Circular RNAs: Characterization, cellular roles, and applications. Cell 185(12):2016\u20132034","journal-title":"Cell"},{"key":"12539_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna7030048","author":"A Das","year":"2021","unstructured":"Das A et al (2021) Emerging Role of Circular RNA-Protein Interactions. Noncoding RNA, 7(3):48 https:\/\/doi.org\/10.3390\/ncrna7030048","journal-title":"Noncoding RNA"},{"key":"12539_CR25","doi-asserted-by":"publisher","DOI":"10.2174\/1874467216666230217151946","author":"Q Zeng","year":"2024","unstructured":"Zeng Q et al (2024) Hsa_Circ_0000021 Sponges miR-3940-3p\/KPNA2 Expression to Promote Cervical Cancer Progression. Curr Mol Pharmacol. 17:e170223213775 https:\/\/doi.org\/10.2174\/1874467216666230217151946","journal-title":"Curr Mol Pharmacol"},{"key":"12539_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H et al (2024) Circular RNA hsa_circ_0005939 Regulates UHRF1BP1L Expression by Targeting miR-4693-3p to Promote Colorectal Cancer Progression. Protein Pept Lett. 31(6):437\u2013446 https:\/\/doi.org\/10.2174\/0109298665297110240611115010","journal-title":"Protein Pept Lett"},{"key":"12539_CR27","doi-asserted-by":"crossref","unstructured":"Li M et al (2019) Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance. Biomed Res Int, 2019: p. 9681863","DOI":"10.1155\/2019\/9681863"},{"issue":"4","key":"12539_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen LL (2016) The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol 17(4):205\u2013211","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"12539_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS et al (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20(11):675\u2013691","journal-title":"Nat Rev Genet"},{"issue":"16","key":"12539_CR30","doi-asserted-by":"publisher","first-page":"e100836","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, W\u00fcst S, Kadener S (2019) Past, present, and future of circRNAs. Embo j 38(16):e100836","journal-title":"Embo j"},{"issue":"9","key":"12539_CR31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1101\/gr.202895.115","volume":"26","author":"XO Zhang","year":"2016","unstructured":"Zhang XO et al (2016) Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res 26(9):1277\u20131287","journal-title":"Genome Res"},{"issue":"12","key":"12539_CR32","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1261\/rna.047126.114","volume":"20","author":"E Lasda","year":"2014","unstructured":"Lasda E, Parker R (2014) Circular RNAs: diversity of form and function. RNA 20(12):1829\u20131842","journal-title":"RNA"},{"key":"12539_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-981-13-1426-1_4","volume":"1087","author":"N Eger","year":"2018","unstructured":"Eger N et al (2018) Circular RNA Splicing. Adv Exp Med Biol 1087:41\u201352","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"12539_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","volume":"12","author":"L Verduci","year":"2021","unstructured":"Verduci L et al (2021) CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis 12(5):468","journal-title":"Cell Death Dis"},{"issue":"6","key":"12539_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/jmedgenet-2016-103758","volume":"53","author":"Y Chen","year":"2016","unstructured":"Chen Y et al (2016) Circular RNAs: a new frontier in the study of human diseases. J Med Genet 53(6):359\u2013365","journal-title":"J Med Genet"},{"issue":"1","key":"12539_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10142-025-01575-4","volume":"25","author":"S Sur","year":"2025","unstructured":"Sur S et al (2025) Emerging role and clinical applications of circular RNAs in human diseases. Funct Integr Genomics 25(1):77","journal-title":"Funct Integr Genomics"},{"key":"12539_CR37","doi-asserted-by":"publisher","first-page":"154697","DOI":"10.1016\/j.prp.2023.154697","volume":"248","author":"A Malviya","year":"2023","unstructured":"Malviya A, Bhuyan R (2023) The recent advancements in circRNA research: From biogenesis to therapeutic interventions. Pathol Res Pract 248:154697","journal-title":"Pathol Res Pract"},{"issue":"3","key":"12539_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tibs.2021.11.004","volume":"47","author":"L Chen","year":"2022","unstructured":"Chen L, Huang C, Shan G (2022) Circular RNAs in physiology and non-immunological diseases. Trends Biochem Sci 47(3):250\u2013264","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"12539_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-019-0776-8","volume":"12","author":"T Yu","year":"2019","unstructured":"Yu T et al (2019) CircRNAs in cancer metabolism: a review. J Hematol Oncol 12(1):90","journal-title":"J Hematol Oncol"},{"issue":"1","key":"12539_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-019-1041-z","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y et al (2019) Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer 18(1):116","journal-title":"Mol Cancer"},{"issue":"1","key":"12539_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-018-0877-y","volume":"17","author":"X Cui","year":"2018","unstructured":"Cui X et al (2018) Emerging function and potential diagnostic value of circular RNAs in cancer. Mol Cancer 17(1):123","journal-title":"Mol Cancer"},{"issue":"1","key":"12539_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41392-021-00569-5","volume":"6","author":"AT He","year":"2021","unstructured":"He AT et al (2021) Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther 6(1):185","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12539_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S et al (2017) CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer 16(1):94","journal-title":"Mol Cancer"},{"key":"12539_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40364-020-00204-5","volume":"8","author":"Z Li","year":"2020","unstructured":"Li Z et al (2020) The emerging landscape of circular RNAs in immunity: breakthroughs and challenges. Biomark Res 8:25","journal-title":"Biomark Res"},{"key":"12539_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells12242813","author":"P Hoque","year":"2023","unstructured":"Hoque P et al (2023) Exploring the Multifaceted Biologically Relevant Roles of circRNAs: From Regulation, Translation to Biomarkers. Cells, 12(24):2813 https:\/\/doi.org\/10.3390\/cells12242813","journal-title":"Cells"},{"key":"12539_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna8030029","author":"K Plawgo","year":"2022","unstructured":"Plawgo K, Raczynska KD (2022) Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs. Noncoding RNA, 8(3):29 https:\/\/doi.org\/10.3390\/ncrna8030029","journal-title":"Noncoding RNA"},{"key":"12539_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ncrna.2024.09.006","volume":"10","author":"M Hashemi","year":"2025","unstructured":"Hashemi M et al (2025) Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response. Noncoding RNA Res 10:98\u2013115","journal-title":"Noncoding RNA Res"},{"issue":"7441","key":"12539_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333\u2013338","journal-title":"Nature"},{"issue":"12","key":"12539_CR49","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/s41418-018-0115-6","volume":"25","author":"L Fang","year":"2018","unstructured":"Fang L et al (2018) Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1. Cell Death Differ 25(12):2195\u20132208","journal-title":"Cell Death Differ"},{"issue":"4","key":"12539_CR50","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2019.01.025","volume":"176","author":"S Chen","year":"2019","unstructured":"Chen S et al (2019) Widespread and Functional RNA Circularization in Localized Prostate Cancer. Cell 176(4):831\u2013843e22","journal-title":"Cell"},{"key":"12539_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna9040038","author":"A Gu","year":"2023","unstructured":"Gu A et al (2023) Functions of Circular RNA in Human Diseases and Illnesses. Noncoding RNA, 9(4):38 https:\/\/doi.org\/10.3390\/ncrna9040038","journal-title":"Noncoding RNA"},{"issue":"6","key":"12539_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun Y et al (2015) Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35(6):600\u2013604","journal-title":"J Recept Signal Transduct Res"},{"key":"12539_CR53","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2174\/0109298665418763251124051527","volume":"32","author":"M Qiu","year":"2025","unstructured":"Qiu M et al (2025) Prolyl 4-Hydroxylase Beta Peptide Promotes Invasion, Migration, and Epithelial-Mesenchymal Transition through Activation of the Claudin-1\/ AMPK\/TGF-beta1 Pathway in Bladder Cancer Cells. Protein Pept Lett. 32(11):822-835. https:\/\/doi.org\/10.2174\/0109298665418763251124051527","journal-title":"Protein Pept Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12539-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:02:12Z","timestamp":1785834132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12539-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12539"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12539-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies for human tissue samples were approved by the Ethics Committee of the Fourth Affiliated Hospital of China Medical University, with informed consent obtained from all participants. All nude mouse xenograft animal experiments in this study were reviewed and approved by the Animal Ethics Committee, ethical approval number: CSE202606001. All animal operations were performed in strict accordance with the guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Obtained from all patients.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI tools were used solely for language checking and polishing; no AI was involved in data generation, analysis, or interpretation. The scientific content, experimental design, and conclusions are entirely the work of the authors. All authors approved this limited use and accepted full responsibility for the manuscript\u2019s accuracy, integrity, and originality.","order":4,"name":"Ethics","label":"Use of artificial intelligence tools","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1337"}}